The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BofA analyst Michael Ryskin lowered the firm’s price target on Icon (ICLR) to $255 from $270 and keeps a Buy rating on the shares. The firm ...

The three listed managers boast 21 years of average listed portfolio management experience. A strength of ICON is its experienced longest-tenured portfolio managers, who have accrued an average 17 ...

Callahan has an experienced backdrop of support. The three listed managers boast 21 years of average listed portfolio management experience. ICON's longest-tenured portfolio management is worth ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.

ICON Public Limited Company ... The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from ...